sec.344LRequirements for keeping of dangerous drugs for training purposes

### sec.344L Requirements for keeping of dangerous drugs for training purposes The following requirements apply for the department’s possession of dangerous drugs for training purposes— each batch of a dangerous drug must be stored in a drug vault; when a batch of a dangerous drug is received into a drug vault for storage for the first time, it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; a drug vault must not be used for storing a dangerous drug that is in the possession of the department other than for training purposes; a drug vault must be designed and constructed for ensuring, to the greatest practicable extent, that each batch of a dangerous drug stored in it keeps its level of effectiveness for training purposes; a drug vault must include enough separate storage to ensure that no batch of a dangerous drug stored in the vault can be contaminated by another batch, or can otherwise be made ineffective or less effective for training purposes; the whole of a batch of a dangerous drug must be stored in a drug vault at all times, except to the extent the batch, or a part of the batch, is required to be held somewhere else for training purposes; an audit of each drug vault must be conducted at least once every 3 months by a corrective services officer not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; when a batch of a dangerous drug leaves a drug vault for the last time— it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; and a copy of the document mentioned in subparagraph (i) must be kept at the drug vault or at another place the chief executive directs. Without limiting the scope of an audit under subsection (1) (g) , the audit must include— weighing each batch of dangerous drugs in the drug vault to find out whether all quantities of dangerous drugs that should be in the drug vault at the time of the audit are in the vault; and finding out whether the drug vault is storing any dangerous drugs, or anything else, that should not be stored in the drug vault; and finding out whether, and to what extent, the purity of any batch of a dangerous drug stored at the drug vault has been adversely affected since it was received into the drug vault; and a review of the register of dangerous drugs for training. Without limiting the requirements for an audit under subsection (1) (g) , requirements for the audit include the following— the performance of the audit must be supervised by a corrective services officer who is— authorised by the chief executive to supervise the performance of the audit; and not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; all batches of dangerous drugs stored in the drug vault must be the subject of analysis by an analyst under the Drugs Misuse Act 1986 ; the accuracy of the scales used in measuring the weights of batches of dangerous drugs stored in the drug vault must be certified in a way approved by the chief executive. s 344L ins 2008 No. 53 s 5 (sec.344L-ssec.1) The following requirements apply for the department’s possession of dangerous drugs for training purposes— each batch of a dangerous drug must be stored in a drug vault; when a batch of a dangerous drug is received into a drug vault for storage for the first time, it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; a drug vault must not be used for storing a dangerous drug that is in the possession of the department other than for training purposes; a drug vault must be designed and constructed for ensuring, to the greatest practicable extent, that each batch of a dangerous drug stored in it keeps its level of effectiveness for training purposes; a drug vault must include enough separate storage to ensure that no batch of a dangerous drug stored in the vault can be contaminated by another batch, or can otherwise be made ineffective or less effective for training purposes; the whole of a batch of a dangerous drug must be stored in a drug vault at all times, except to the extent the batch, or a part of the batch, is required to be held somewhere else for training purposes; an audit of each drug vault must be conducted at least once every 3 months by a corrective services officer not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; when a batch of a dangerous drug leaves a drug vault for the last time— it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; and a copy of the document mentioned in subparagraph (i) must be kept at the drug vault or at another place the chief executive directs. (sec.344L-ssec.2) Without limiting the scope of an audit under subsection (1) (g) , the audit must include— weighing each batch of dangerous drugs in the drug vault to find out whether all quantities of dangerous drugs that should be in the drug vault at the time of the audit are in the vault; and finding out whether the drug vault is storing any dangerous drugs, or anything else, that should not be stored in the drug vault; and finding out whether, and to what extent, the purity of any batch of a dangerous drug stored at the drug vault has been adversely affected since it was received into the drug vault; and a review of the register of dangerous drugs for training. (sec.344L-ssec.3) Without limiting the requirements for an audit under subsection (1) (g) , requirements for the audit include the following— the performance of the audit must be supervised by a corrective services officer who is— authorised by the chief executive to supervise the performance of the audit; and not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; all batches of dangerous drugs stored in the drug vault must be the subject of analysis by an analyst under the Drugs Misuse Act 1986 ; the accuracy of the scales used in measuring the weights of batches of dangerous drugs stored in the drug vault must be certified in a way approved by the chief executive. - (a) each batch of a dangerous drug must be stored in a drug vault; - (b) when a batch of a dangerous drug is received into a drug vault for storage for the first time, it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; - (c) a drug vault must not be used for storing a dangerous drug that is in the possession of the department other than for training purposes; - (d) a drug vault must be designed and constructed for ensuring, to the greatest practicable extent, that each batch of a dangerous drug stored in it keeps its level of effectiveness for training purposes; - (e) a drug vault must include enough separate storage to ensure that no batch of a dangerous drug stored in the vault can be contaminated by another batch, or can otherwise be made ineffective or less effective for training purposes; - (f) the whole of a batch of a dangerous drug must be stored in a drug vault at all times, except to the extent the batch, or a part of the batch, is required to be held somewhere else for training purposes; - (g) an audit of each drug vault must be conducted at least once every 3 months by a corrective services officer not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; - (h) when a batch of a dangerous drug leaves a drug vault for the last time— (i) it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; and (ii) a copy of the document mentioned in subparagraph (i) must be kept at the drug vault or at another place the chief executive directs. - (i) it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; and - (ii) a copy of the document mentioned in subparagraph (i) must be kept at the drug vault or at another place the chief executive directs. - (i) it must be accompanied by a document certifying, in a way approved by the chief executive, the weight and purity of the batch; and - (ii) a copy of the document mentioned in subparagraph (i) must be kept at the drug vault or at another place the chief executive directs. - (a) weighing each batch of dangerous drugs in the drug vault to find out whether all quantities of dangerous drugs that should be in the drug vault at the time of the audit are in the vault; and - (b) finding out whether the drug vault is storing any dangerous drugs, or anything else, that should not be stored in the drug vault; and - (c) finding out whether, and to what extent, the purity of any batch of a dangerous drug stored at the drug vault has been adversely affected since it was received into the drug vault; and - (d) a review of the register of dangerous drugs for training. - (a) the performance of the audit must be supervised by a corrective services officer who is— (i) authorised by the chief executive to supervise the performance of the audit; and (ii) not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; - (i) authorised by the chief executive to supervise the performance of the audit; and - (ii) not otherwise directly associated with the keeping or use of dangerous drugs for training purposes; - (b) all batches of dangerous drugs stored in the drug vault must be the subject of analysis by an analyst under the Drugs Misuse Act 1986 ; - (c) the accuracy of the scales used in measuring the weights of batches of dangerous drugs stored in the drug vault must be certified in a way approved by the chief executive. - (i) authorised by the chief executive to supervise the performance of the audit; and - (ii) not otherwise directly associated with the keeping or use of dangerous drugs for training purposes;